BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32979728)

  • 1. Why magnesium sulfate 'coverage' only is not enough to reduce eclampsia: Lessons learned in a middle-income country.
    Verschueren KJC; Paidin RR; Broekhuis A; Ramkhelawan OSS; Kodan LR; Kanhai HHH; Browne JL; Bloemenkamp KWM; Rijken MJ
    Pregnancy Hypertens; 2020 Oct; 22():136-143. PubMed ID: 32979728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-labelled randomised controlled trial of 12 hours versus 24 hours modified Pritchard regimen in the management of eclampsia and pre-eclampsia in Ghana (MOPEP Study): study protocol.
    Beyuo T; Lawrence E; Langen ES; Oppong SA
    BMJ Open; 2019 Oct; 9(10):e032799. PubMed ID: 31641005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loading dose versus standard regime of magnesium sulfate in the management of eclampsia: a randomized trial.
    Begum MR; Begum A; Quadir E
    J Obstet Gynaecol Res; 2002 Jun; 28(3):154-9. PubMed ID: 12214831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal outcomes after 12hours and 24hours of magnesium sulfate therapy for eclampsia.
    Anjum S; Goel N; Sharma R; Mohsin Z; Garg N
    Int J Gynaecol Obstet; 2016 Jan; 132(1):68-71. PubMed ID: 26604159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens.
    Gordon R; Magee LA; Payne B; Firoz T; Sawchuck D; Tu D; Vidler M; de Silva D; von Dadelszen P
    J Obstet Gynaecol Can; 2014 Feb; 36(2):154-163. PubMed ID: 24518915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loading Dose only versus Standard Dose Magnesium Sulfate Seizure Prophylaxis in Severe Pre-eclamptic Women.
    Rimal SP; Rijal P; Bhatt R; Thapa K
    JNMA J Nepal Med Assoc; 2017; 56(208):388-94. PubMed ID: 29453467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intramuscular magnesium sulfate with low dose intravenous magnesium sulfate regimen for treatment of eclampsia.
    Chowdhury JR; Chaudhuri S; Bhattacharyya N; Biswas PK; Panpalia M
    J Obstet Gynaecol Res; 2009 Feb; 35(1):119-25. PubMed ID: 19215558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel 12-hour versus 24-hour magnesium sulfate regimen in the management of eclampsia and preeclampsia in Ghana (MOPEP Study): A randomized controlled trial.
    Beyuo TK; Lawrence ER; Kobernik EK; Oppong SA
    Int J Gynaecol Obstet; 2022 Nov; 159(2):495-504. PubMed ID: 35304745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium sulphate: a life saving drug.
    Thapa K; Jha R
    JNMA J Nepal Med Assoc; 2008; 47(171):104-8. PubMed ID: 19079372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study.
    Wolf HT; Huusom L; Weber T; Piedvache A; Schmidt S; Norman M; Zeitlin J;
    BMJ Open; 2017 Jan; 7(1):e013952. PubMed ID: 28132012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of intramuscular loading dose of MgSO4 in severe pre-eclampsia/ eclampsia at a tertiary referral centre in Northwest Nigeria.
    Okusanya BO; Garba KD; Ibrahim HM
    Niger Postgrad Med J; 2012 Jun; 19(2):77-82. PubMed ID: 22728971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal and perinatal outcomes of eclampsia: Nova Scotia, 1981-2000.
    Lee W; O'Connell CM; Baskett TF
    J Obstet Gynaecol Can; 2004 Feb; 26(2):119-23. PubMed ID: 14965477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An audit of the use of magnesium sulphate in severe pre-eclampsia and eclampsia.
    Singh J; O'Donovan M; Coulter-Smith SD; Geary M
    J Obstet Gynaecol; 2005 Jan; 25(1):15-7. PubMed ID: 16147685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and perinatal outcome of severe pre-eclampsia in Enugu, Nigeria after introduction of Magnesium sulfate.
    Ugwu EO; Dim CC; Okonkwo CD; Nwankwo TO
    Niger J Clin Pract; 2011; 14(4):418-21. PubMed ID: 22248941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of using magnesium sulphate (MgSO₄) for eclampsia management and maternal mortality reduction: lessons from Kano State in Northern Nigeria.
    Okereke E; Ahonsi B; Tukur J; Ishaku SM; Oginni AB
    BMC Res Notes; 2012 Aug; 5():421. PubMed ID: 22873658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
    Omu AE; Al-Harmi J; Vedi HL; Mlechkova L; Sayed AF; Al-Ragum NS
    Med Princ Pract; 2008; 17(3):227-32. PubMed ID: 18408392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial.
    Vigil-De Gracia P; Ramirez R; Durán Y; Quintero A
    BMC Pregnancy Childbirth; 2017 Jul; 17(1):241. PubMed ID: 28738788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
    Riaz M; Porat R; Brodsky NL; Hurt H
    J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia.
    Okusanya BO; Oladapo OT; Long Q; Lumbiganon P; Carroli G; Qureshi Z; Duley L; Souza JP; Gülmezoglu AM
    BJOG; 2016 Feb; 123(3):356-66. PubMed ID: 26599617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loading dose versus standard regimen of magnesium sulphate in eclampsia--a randomized trial.
    Regmi MC; Aggrawal A; Pradhan T; Rijal P; Subedi A; Uprety D
    Nepal Med Coll J; 2010 Dec; 12(4):244-7. PubMed ID: 21744767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.